Infinium Global Research has added a new report on Global Cancer Therapeutics and Supportive Care Drugs Market. The report covers the analysis of global as well as regional markets of cancer therapeutics and supportive care drugs. Moreover, the report gives insights into the factors that affect the global as well as regional performance of the market in the short run and in the long run. According to the report, the global cancer therapeutics and supportive care drugs market is projected to grow at a CAGR of 9.4 % over the forecast period of 2019-2025.
Ask for Sample Copy of Research Report with Table of Content @ https://www.infiniumglobalresearch.com/reports/sample-request/5948
Cancer is an abnormal growth of cells and it is also known as malignancy. There are more than 100 types of cancer, including breast cancer, skin cancer, lung cancer, colon cancer, prostate cancer, and lymphoma. Symptoms vary depending on the type. Cancer treatment may include chemotherapy, radiation, and/or surgery. New trends in oncology drug development are reflected in the increasing use of biotechnology in the development of anticancer drugs, including immunotherapies or monoclonal antibodies, adoptive-cell therapies, and new vaccines.
New treatment options have become available in the past five years, and the surge of innovation is expected to continue due to a robust pipeline of drugs in clinical development by a large and diverse group of pharmaceutical companies. Innovations in the development of new drugs and therapies, a large number of new drugs entering into the market with FDA approval, increasing prevalence of cancerous patients, availability of new treatment options in the market and rise in base of aging the population is the key driving factors for the growth of this market.
In addition, changing lifestyle habits of populations increased patient’s healthcare awareness and increasing demand for non-invasive therapies are further expected to propel the market growth in the coming years. Along with these driving factors, the market for cancer therapeutics is facing some challenges such as time-consuming regulatory compliance and the high cost of cancer drugs. However, the market for cancer therapeutics and supportive care drugs is likely to rise in the future due to a large number of ongoing innovations for the treatment of cancer.
North America is the Leading Contributor to the Market
Geographically, North America is the leading contributor to the market, and it is expected to retain its position during the forecast period due to high awareness, the presence of a large base of cancer patients, rise in investments, and various initiatives by government in the healthcare sector. However, the Asia-Pacific market is expected to grow at a faster rate during the forecast period. This is predominantly due to increased healthcare awareness, technological advancements, significant investments and growing awareness among the population about the treatment options available in the market.
Cancer Therapeutics and Supportive Care Drugs Market: Segmentation
The report on global cancer therapeutics and supportive care drugs market covers segments such as drug class and distribution channel. On the basis of drug class, the sub-markets include ESAS, bisphosphonates, opioids, G-CSFS, antiemetics, NSAIDs, and other drug classes. On the basis of distribution channel, the sub-markets include hospital and retail.
Cancer Therapeutics and Supportive Care Drugs Market: Competitive Landscape
The report provides profiles of the companies in the market such as Takeda Pharmaceutical Company Ltd, Teva Pharmaceutical Industries Ltd., AbbVie Inc., Sanofi S.A, Eli Lilly and Company, Novartis International AG, Pfizer Inc, Johnson & Johnson, Bristol-Myers Squibb Company, Astellas Pharma Inc, and Other companies.
Browse Detailed TOC, Description, and Companies Mentioned in Report @ https://www.infiniumglobalresearch.com/healthcare-medical-devices/global-cancer-therapeutics-and-supportive-care-drugs-market
Reasons to Buy this Report:
- Comprehensive analysis of global as well as regional markets of the cancer therapeutics and supportive care drugs.
- Complete coverage of all the product type and applications segments to analyze the trends, developments, and forecast of market size up to 2025.
- Comprehensive analysis of the companies operating in this market. The company profile includes analysis of product portfolio, revenue, SWOT analysis and the latest developments of the company.
- Infinium Global Research- Growth Matrix presents an analysis of the product segments and geographies that market players should focus to invest, consolidate, expand and/or diversify.